Researcher

Mengxin Li

China-New Zealand Joint Laboratory of Biomedicine and Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, People's Republic of China.

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 12, 2026 · JOURNAL ARTICLE

Targeted delivery of mRNA to immune cells for in vivo cell therapy.

Drug Delivery

A comprehensive review article synthesizing current knowledge on mRNA delivery engineering strategies to immune cells, identifying translational barriers and technical advances rather than reporting original experimental results or clinical outcomes.

Expert GuidanceNanoparticles Jinfeng Deng Yumin Li

Reported

Ex vivo CAR-T manufacturing durat…typically 3–4 weeks